Personally I assume that anything under $10 is questionable... a red flag; no doubt others do too. Under $5 is out of the question for me.
Note that most IPOs are priced from $10-$20. Wall Street probably figures that's the sweet spot for IPO "players." For older, more experienced, conservative investors the sweet spot is surely higher than that range.
It's would be pretty sad if CIM were worried about falling under a buck, the NYSE minimum.
Recent CIM News
- Chimera Investment Corporation Announces Date of First Quarter 2024 Financial Results and Conference Call • Business Wire • 04/24/2024 08:15:00 PM
- Chimera Declares First Quarter 2024 Common Stock Dividends • Business Wire • 03/28/2024 08:30:00 PM
- Chimera Declares First Quarter 2024 Preferred Stock Dividends • Business Wire • 02/14/2024 12:15:00 PM
- CHIMERA INVESTMENT CORPORATION REPORTS 4TH QUARTER 2023 EARNINGS • Business Wire • 02/14/2024 12:00:00 PM
- Chimera Investment Corporation Announces Date of Fourth Quarter and Full Year 2023 Financial Results and Conference Call • Business Wire • 01/30/2024 09:30:00 PM
- CHIMERA INVESTMENT CORPORATION REPORTS 3RD QUARTER 2023 EARNINGS • Business Wire • 11/02/2023 10:30:00 AM
- Chimera Declares Fourth Quarter 2023 Common and Preferred Stock Dividends • Business Wire • 11/02/2023 10:30:00 AM
- Chimera Appoints New Independent Board Member Susan Mills • Business Wire • 11/01/2023 11:12:00 PM
- Chimera Investment Corporation Announces Date of Third Quarter 2023 Financial Results and Conference Call • Business Wire • 10/18/2023 08:30:00 PM
- Chimera Declares Third Quarter 2023 Common and Preferred Stock Dividends • Business Wire • 08/03/2023 11:00:00 AM
- CHIMERA INVESTMENT CORPORATION REPORTS 2ND QUARTER 2023 EARNINGS • Business Wire • 08/03/2023 11:00:00 AM
- Chimera Investment Corporation Announces Date of Second Quarter 2023 Financial Results and Conference Call • Business Wire • 07/21/2023 08:30:00 PM
- Chimera Investment Corporation Announces 2nd Quarter 2023 Common Stock Dividend and Increase in Share Repurchase Program • Business Wire • 06/14/2023 08:30:00 PM
- Chimera Announces Revised Ex-Dividend Date for Second Quarter Preferred Stock Cash Dividend – Payment Amount, Payable Date and Record Date Unchanged • Business Wire • 06/05/2023 11:00:00 AM
- Chimera Declares Second Quarter 2023 Preferred Stock Dividends • Business Wire • 06/01/2023 08:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM